World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
33446
World Ranking
1239
National Ranking
108

Overview

Miles W. Carroll is a researcher affiliated with the University of Oxford in the United Kingdom. Their academic work primarily focuses on medicine, with a strong emphasis on infectious diseases, epidemiology, molecular biology, animal science and zoology, and immunology.

Their research extensively covers several topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors
  • SARS-CoV-2 detection and testing
  • COVID-19 epidemiological studies

Miles W. Carroll has contributed to multiple publications, with notable recent papers as follows:

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (2020, The Lancet)
  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera (2021, Cell)
  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (2022, Cell)
  • Animal models for COVID-19 (2020, Nature)
  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (2021, Cell)

Their research has appeared frequently in several publication venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • SSRN Electronic Journal
  • Frontiers in Immunology
  • Cell

They have collaborated regularly with a group of co-authors, among the most frequent being:

  • Eleanor Barnes
  • Paul Klenerman
  • Tom Tipton
  • Susanna Dunachie
  • Gavin Screaton

Best Publications

  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

    Unknown

  • Real-time, portable genome sequencing for Ebola surveillance

    Joshua Quick;Nicholas J. Loman;Sophie Duraffour;Jared T. Simpson;Jared T. Simpson

  • Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

    Ana Maria Henao-Restrepo;Anton Camacho;Ira M. Longini;Conall H. Watson

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

    Joshua Quick;Nathan D Grubaugh;Steven T Pullan;Ingra M Claro

  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

    D Zhou;W Dejnirattisai;P Supasa;C Liu

  • Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

    Ana Maria Henao-Restrepo;Ira M Longini;Matthias Egger;Matthias Egger;Natalie E Dean

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Immunogenicity of a DNA vaccine candidate for COVID-19.

    Trevor R.F. Smith;Ami Patel;Stephanie Ramos;Dustin Elwood

  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

    C Liu;H M Ginn;W Dejnirattisai;P Supasa

  • GP100/PMEL 17 IS A MURINE TUMOR REJECTION ANTIGEN : INDUCTION OF SELF -REACTIVE, TUMORICIDAL T CELLS USING HIGH-AFFINITY, ALTERED PEPTIDE LIGAND

    Willem W. Overwijk;Allan Tsung;Kari R. Irvine;Maria R. Parkhurst

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • Antibody evasion by the P.1 strain of SARS-CoV-2.

    W Dejnirattisai;D Zhou;P Supasa;C Liu

  • Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

    Daouda Sissoko;Cedric Laouenan;Elin Folkesson;Abdoul-Bing M’Lebing

  • Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes

    Willem W. Overwijk;David S. Lee;Deborah R. Surman;Kari R. Irvine

  • Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

    J Huo;J Huo;A Le Bas;A Le Bas;R R Ruza;Duyvesteyn Hme.

  • Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

    P Supasa;D Zhou;W Dejnirattisai;C Liu

  • Virus genomes reveal factors that spread and sustained the Ebola epidemic

    Gytis Dudas;Gytis Dudas;Luiz Max Carvalho;Trevor Bedford;Andrew J. Tatem

  • Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

    V M Hirsch;T R Fuerst;G Sutter;M W Carroll

  • Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.

    Andrew D Davidson;Maia Kavanagh Williamson;Sebastian D Lewis;Deborah K Shoemark

  • Host Range and Cytopathogenicity of the Highly Attenuated MVA Strain of Vaccinia Virus: Propagation and Generation of Recombinant Viruses in a Nonhuman Mammalian Cell Line

    Miles W Carroll;Bernard Moss

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Julian A. Hiscox
Julian A. Hiscox University of Liverpool
Philippa C. Matthews
Philippa C. Matthews University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Juthathip Mongkolsapaya
Juthathip Mongkolsapaya University of Oxford
Susan M. Kingsman
Susan M. Kingsman Oxford BioMedica (United Kingdom)
Derrick W. Crook
Derrick W. Crook University of Oxford
Gavin R. Screaton
Gavin R. Screaton University of Oxford
Stephan Günther
Stephan Günther Bernhard Nocht Institute for Tropical Medicine
Raymond J. Owens
Raymond J. Owens University of Oxford
Alain Townsend
Alain Townsend University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields through online degrees can open valuable career opportunities. Programs such as the easiest fnp program provide a flexible pathway to become a Family Nurse Practitioner, gaining clinical skills that complement immunology knowledge.

Mental health is another critical area connected to immunological research, with growing demand for specialists. The best pmhnp programs online offer strong clinical placement rates, preparing graduates for roles as Psychiatric-Mental Health Nurse Practitioners. Affordability also plays a key role, and prospective students can find quality options like cheap psych np programs that balance cost with comprehensive training.

Graduates often pursue advanced degrees such as the Doctor of Nursing Practice (DNP), which can lead to higher earning potential. Understanding compensation is crucial, and resources like doctor of nursing practice salary provide insights into expected income across different states.

By leveraging these online degree options and exploring career pathways aligned with immunology, students can tailor their education to meet both clinical and research interests, maximizing their impact in healthcare.

Best Scientists Citing Miles W. Carroll

Trending Scientists

Recently Published Articles